openPR Logo
Press release

The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of CRA

03-21-2011 08:56 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Levi & Korsinsky, LLP

Levi & Korsinsky is investigating the Board of Directors of Celera Corporation (“Celera” or the “Company”) (NYSE: CRA) for possible breaches of fiduciary duty in connection with the sale of the Company to Quest Diagnostics Incorporated.

New York, NY, March 21, 2011 -- Levi & Korsinsky is investigating the Board of Directors of Celera Corporation (“Celera” or the “Company”) (NYSE: CRA) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Quest Diagnostics Incorporated (“Quest Diagnostics”) (NYSE: DGX). Under the terms of the transaction, Quest Diagnostics would acquire Celera shares at $8 in cash per share, for a total transaction value of approximately $344 million.

Click here to learn more about the investigation: http://www.zlk.com/celera-corporation-cra.html, or call: 877-363-5972.

The investigation concerns whether the Celera Board of Directors breached their fiduciary duties to Celera stockholders by failing to adequately shop the Company before entering into this transaction and whether Quest Diagnostics is underpaying for Celera shares, thus unlawfully harming Celera stockholders.

If you own common stock in Celera and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/celera-corporation-cra.html.

Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact: Levi & Korsinsky, LLP, Joseph Levi, Esq., Eduard Korsinsky, Esq., 30 Broad Street - 15th Floor, New York, NY 10004, Tel: (212) 363-7500, Toll Free: (877) 363-5972, Fax: (212) 363-7171, http://www.zlk.com

Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation

Joanna Chlebus
Levi & Korsinsky, LLP
30 Broad St, 15th Floor
New York, NY 10004
212-363-7500
jchlebus@zlk.com
http://www.zlk.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of CRA here

News-ID: 167363 • Views: 1047

More Releases from Levi & Korsinsky, LLP

The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Se …
Levi & Korsinsky is investigating potential claims on behalf of purchasers of the securities of China Automotive Systems, Inc. (“China Automotive” or the “Company”) (Nasdaq: CAAS) concerning possible violations of federal securities laws. New York, NY, March 24, 2011 -- Levi & Korsinsky is investigating potential claims on behalf of purchasers of the securities of China Automotive Systems, Inc. (“China Automotive” or the “Company”) (Nasdaq: CAAS) concerning possible violations of federal
The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Vi …
Levi & Korsinsky, LLP is investigating TETRA Technologies, Inc. (NYSE: TTI), and its Board of Directors, for possible violations of federal securities laws in connection with the upcoming May 3, 2011 shareholder vote. New York, NY, March 23, 2011 -- Levi & Korsinsky, LLP is investigating TETRA Technologies, Inc. (NYSE: TTI), and its Board of Directors, for possible violations of federal securities laws in connection with the upcoming May 3, 2011
The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Vi …
Levi & Korsinsky, LLP is investigating Cincinnati Financial Corporation (“Cincinnati Financial” or the “Company”) (NASDAQ: CINF), and its Board of Directors, for possible violations of federal securities laws in connection with the upcoming April 30, 2011 shareholder vote. New York, NY, March 22, 2011 -- Levi & Korsinsky, LLP is investigating Cincinnati Financial Corporation (“Cincinnati Financial” or the “Company”) (NASDAQ: CINF), and its Board of Directors, for possible violations of federal
The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Se …
Levi & Korsinsky is investigating potential claims on behalf of purchasers of the securities of Kid Brands, Inc. (NYSE: KID) concerning possible violations of federal securities laws. New York, NY, March 22, 2011 -- Levi & Korsinsky is investigating potential claims on behalf of purchasers of the securities of Kid Brands, Inc. (NYSE: KID) concerning possible violations of federal securities laws. On March 15, 2011, Kid Brands announced it would delay the

All 5 Releases


More Releases for Celera

Global Tissue Transplantation Products and Services Market || keyplayers Abbott, …
Chronic diseases also lead to cataclysmic damages to many organs. This harm is typically irreparable and lifetime reliance on medicines. In such conditions, transplantation of organs remains the only option for healthy living. Worldwide, there has been an increase in tissue and organ transplant with advanced technology. This surge in transplantation of tissue and organ is mainly from high-income countries. Rising incidence and prevalence of chronic diseases such as cancer,
Genetic Disease Diagnostic Market by Growth Analysis 2029 | Abbott, Celera Group …
Los Angeles, United State -The report titled "Global Genetic Disease Diagnostic Market Research Report 2020" is one of the most comprehensive and important additions to QY Research's archive of market research studies. It offers detailed research and analysis of key aspects of the global Genetic Disease Diagnostic market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a
Tissue Transplantation Products and Services Market Growth, Analysis, Research A …
Chronic diseases often lead to catastrophic damage to vital organs. This damage is usually irreversible and leads to lifetime dependency on medicines. Under such severe conditions, transplants remain the mainstay for restoration of healthy life. Globally, there has been a surge in tissue transplant with advances in medical biotechnology. Tissue transplantation and services market has seen an increased demand especially from high income countries. Higher prevalence of diseases such as
Genetic Testing Market Key Players Celera Group, PerkinElmer Inc., Quest Diagnos …
Molecular diagnostics market is growing at a significant rate due to increasing awareness for the same and rising investments in the field. Genetic testing refers to a process of analysis of human DNA in any of its form or related products such as RNA, chromosomes, DNA and others. Genetic testing is widely used for detection of diseases that are related to genotype, phenotype or mutation. Also, genetic testing is done
Bioinformatics Market Analysis 2023 by Key Players - Affymetrix, Agilent Technol …
The introduction and adoption of cloud computing and nanopore technology are expected to offer numerous opportunities in the global bioinformatics market. The nanopore technology has been projected for getting used in the study of crop science, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), proteins and small molecules with a range of applications in personalized medicine, and scientific research. Browse report sample at: https://www.psmarketresearch.com/market-analysis/bioinformatics-market/report-sample Some of the key competitors within the global bioinformatics market
Genetic Testing Market Explores Outstanding Growth on Bayer Diagnostics, Biocart …
The 2018-2024 report on global Genetic Testing market explores the essential factors of Genetic Testing industry covering current scenario, market demand information, coverage of active companies and segmentation forecasts. Genetic Testing Market will reach USD 22.5 billion by 2024. Diagnostic testing dominated the genetic testing market and accounted for USD 5,690.6 million in 2017. It is expected to witness robust growth during the forecast period attributable to the increasing prevalence